Eversense news for Germany, Italy, Netherlands, Poland, Spain, and Switzerland. Click here to learn more

Contact Us

Personal Information

Agreement

Thank you for your interest in Eversense CGM. Please note that your submission will be subject to the terms and protections of our Privacy Policy (see link below). A member of our Senseonics team or our distribution partners will respond to you.

MKT-001516 Rev 1

Disclaimer

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

The Eversense®XL Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 180 days. It is intended to complement, not replace, fingerstick blood glucose monitoring. The sensor insertion and removal procedures are performed by a health care provider. The Eversense XL CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see global.eversensediabetes.com/safety-info.